The panel members have substantial clinical experience in the diagnosis and treatment of patients with rare metabolic diseases, including patients diagnosed and treated for ARG1-D, which is notably the rarest disease among urea cycle disorders. This evidence concerns the gene ARG1 and Other metabolic disease.